Report of Foreign Issuer (6-k)
April 29 2020 - 8:22AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the
month of April 2020
Commission
File Number 001-15170
GlaxoSmithKline plc
(Translation
of registrant's name into English)
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F . . . .X. . . . Form 40-F . . . . . . . .
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(7): ____
GlaxoSmithKline plc
(the "Company")
Arrangements for Shareholder Webcast - Wednesday 6 May
2020
Further to the Company's announcement on 9 April 2020 that this
year's Annual General Meeting ("AGM") will be run as a closed
meeting due to the UK Government's restrictions on public
gatherings as a result of the COVID-19 pandemic, the Company is
pleased to announce that it will be holding a live webcast for
shareholders following the AGM on Wednesday 6 May
2020.
Details of Shareholder Webcast
The webcast will take place following the AGM
on Wednesday 6 May
2020. It will commence at
2.45pm (UK time) and finish at 3.45pm (UK time). Any changes to
these times will be published on the Company's website
at www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/.
Shareholders wishing to join the webcast are strongly encouraged to
join online. For those shareholders who are not able to join
online, a telephone conference call facility will be
available.
For details on how to register for the webcast online or to dial-in
to the telephone conference call please go
to www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/. Shareholders
who wish to join the webcast online are requested to register as
soon as possible and ideally at least 24 hours before the start of
the webcast.
Please note that the webcast is intended for shareholders only.
Shareholders will therefore be asked to provide their details
before accessing the event.
During the webcast, updates will be given by Sir Jonathan Symonds,
GSK's Chairman, and Emma Walmsley, Chief Executive
Officer.
Following these there will be an opportunity for shareholders to
ask questions. Shareholders may also submit their questions in
advance of the webcast by emailing company.secretary@gsk.com.
The Board will endeavour to ensure that all questions are answered
either during the webcast or by publishing them on the Company's
website after the webcast.
Please note that no inside information will be provided during the
webcast.
The Board would like to take this opportunity to thank all
shareholders for their continued support and understanding in these
exceptional circumstances.
V A Whyte
Company Secretary
29 April 2020
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorised.
|
GlaxoSmithKline plc
|
|
(Registrant)
|
|
|
Date: April
29, 2020
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GlaxoSmithKline plc
|
GSK (PK) (USOTC:GLAXF)
Historical Stock Chart
From Jun 2024 to Jul 2024
GSK (PK) (USOTC:GLAXF)
Historical Stock Chart
From Jul 2023 to Jul 2024